- Home
- JWEL vs PRFX Comparison
JWEL vs PRFX Comparison
Compare JWEL & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- PRFX
- Stock Information
- Founded
- JWEL 2012
- PRFX 2007
- Country
- JWEL China
- PRFX Israel
- Employees
- JWEL N/A
- PRFX N/A
- Industry
- JWEL Other Consumer Services
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- JWEL Consumer Discretionary
- PRFX Health Care
- Exchange
- JWEL Nasdaq
- PRFX Nasdaq
- Market Cap
- JWEL 4.1M
- PRFX 3.6M
- IPO Year
- JWEL 2021
- PRFX 2020
- Fundamental
- Price
- JWEL $1.83
- PRFX $1.47
- Analyst Decision
- JWEL
- PRFX Hold
- Analyst Count
- JWEL 0
- PRFX 1
- Target Price
- JWEL N/A
- PRFX N/A
- AVG Volume (30 Days)
- JWEL 3.5K
- PRFX 43.0K
- Earning Date
- JWEL 07-01-2025
- PRFX 08-14-2025
- Dividend Yield
- JWEL N/A
- PRFX N/A
- EPS Growth
- JWEL N/A
- PRFX N/A
- EPS
- JWEL N/A
- PRFX N/A
- Revenue
- JWEL $132,981,531.00
- PRFX N/A
- Revenue This Year
- JWEL N/A
- PRFX N/A
- Revenue Next Year
- JWEL N/A
- PRFX N/A
- P/E Ratio
- JWEL N/A
- PRFX N/A
- Revenue Growth
- JWEL N/A
- PRFX N/A
- 52 Week Low
- JWEL $1.18
- PRFX $1.46
- 52 Week High
- JWEL $3.71
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- JWEL 36.80
- PRFX 28.27
- Support Level
- JWEL $1.87
- PRFX $1.46
- Resistance Level
- JWEL $1.99
- PRFX $1.76
- Average True Range (ATR)
- JWEL 0.06
- PRFX 0.10
- MACD
- JWEL -0.01
- PRFX -0.05
- Stochastic Oscillator
- JWEL 0.00
- PRFX 2.15
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.